FDA Brief

Warning letters Biologics

FDA warning letter to

O3UV, LLC

Issued Jul 7, 2025Posted Jul 22, 2025Center for Biologics Evaluation and Research (CBER)

Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device. We haven't summarized this letter yet. Read it on fda.gov.